Maia Biotechnology Inc. announced an amendment to its bylaws, approved by stockholders on May 22, 2025, to increase its authorized common stock from 70 million shares to 150 million shares. The amendment was filed with the Delaware Secretary of State on the same day.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maia Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-012192), on May 23, 2025, and is solely responsible for the information contained therein.